ISK is going to the BIO conference 2015
ISK was selected for the 5th time to represent Israel in the BIO conference in philadelphia
Preparing for Phase IIa
#httpvimeocom38805205
Clinical trial: Phase I Dose Escalation completed successfully with exciting results
To date, 15 patients with advanced/metastatic solid tumors have been enrolled (3+3 protocol). Toxicity: MTD has not been reached....